Formosa Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 28.53 million. Net loss was TWD 400.88 million compared to TWD 219.66 million a year ago.

Basic loss per share from continuing operations was TWD 4.33 compared to TWD 3.12 a year ago.